1. Home
  2. CVGW vs GLUE Comparison

CVGW vs GLUE Comparison

Compare CVGW & GLUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVGW
  • GLUE
  • Stock Information
  • Founded
  • CVGW 1924
  • GLUE 2019
  • Country
  • CVGW United States
  • GLUE United States
  • Employees
  • CVGW N/A
  • GLUE N/A
  • Industry
  • CVGW Specialty Foods
  • GLUE Biotechnology: Pharmaceutical Preparations
  • Sector
  • CVGW Consumer Discretionary
  • GLUE Health Care
  • Exchange
  • CVGW Nasdaq
  • GLUE Nasdaq
  • Market Cap
  • CVGW 517.5M
  • GLUE 475.5M
  • IPO Year
  • CVGW N/A
  • GLUE 2021
  • Fundamental
  • Price
  • CVGW $26.15
  • GLUE $7.79
  • Analyst Decision
  • CVGW Hold
  • GLUE Buy
  • Analyst Count
  • CVGW 1
  • GLUE 3
  • Target Price
  • CVGW $32.00
  • GLUE $14.67
  • AVG Volume (30 Days)
  • CVGW 122.3K
  • GLUE 1.5M
  • Earning Date
  • CVGW 01-14-2025
  • GLUE 11-07-2024
  • Dividend Yield
  • CVGW 1.88%
  • GLUE N/A
  • EPS Growth
  • CVGW N/A
  • GLUE N/A
  • EPS
  • CVGW N/A
  • GLUE N/A
  • Revenue
  • CVGW $1,011,635,000.00
  • GLUE $14,975,000.00
  • Revenue This Year
  • CVGW N/A
  • GLUE N/A
  • Revenue Next Year
  • CVGW $3.27
  • GLUE N/A
  • P/E Ratio
  • CVGW N/A
  • GLUE N/A
  • Revenue Growth
  • CVGW 45.46
  • GLUE N/A
  • 52 Week Low
  • CVGW $20.30
  • GLUE $3.21
  • 52 Week High
  • CVGW $31.26
  • GLUE $12.40
  • Technical
  • Relative Strength Index (RSI)
  • CVGW 39.54
  • GLUE 42.82
  • Support Level
  • CVGW $26.02
  • GLUE $7.36
  • Resistance Level
  • CVGW $26.99
  • GLUE $10.69
  • Average True Range (ATR)
  • CVGW 0.77
  • GLUE 0.89
  • MACD
  • CVGW -0.07
  • GLUE -0.30
  • Stochastic Oscillator
  • CVGW 15.38
  • GLUE 9.29

About CVGW Calavo Growers Inc.

Calavo Growers Inc is in the avocado industry and an expanding provider of value-added fresh food. The company distributes its products both domestically and internationally and reports its operations in two different business segments: Grown and Prepared. The Grown segment consists of fresh avocados, tomatoes, and papayas. The Prepared segment comprises all other products including fresh-cut fruits and vegetables, ready-to-eat sandwiches, wraps, salads and snacks, guacamole, and salsa sold at retail and food service as well as avocado pulp sold to food service.

About GLUE Monte Rosa Therapeutics Inc.

Monte Rosa Therapeutics Inc is a biotechnology company that specializes in developing molecular glue degraders (MGDs), a class of small molecule drugs that leverage the body's natural protein destruction mechanisms to selectively degrade therapeutically-relevant proteins. Utilizing the QuEEN platform, the company employ artificial intelligence and proprietary experimental tools to identify target proteins for degradation by MGDs. With a diverse library of over 50,000 MGD molecules, their most advanced product candidate, MRT-2359, targets the translation termination factor protein GSPT1 for potential use in MYC-driven tumors. The company's focus lies in advancing its pipeline of MGDs, aiming to provide novel therapeutic modalities for various diseases.

Share on Social Networks: